Dong-sheng Liu

发表

Overexpression of Tim-3 reduces Helicobacter pylori-associated inflammation through TLR4/NFκB signaling in vitro.

Yong Xie, Zhi-Jie Mao, Nan-jin Zhou, 2017, Molecular medicine reports.

The Activity of Liposomal Linolenic Acid Against Helicobacter pylori In Vitro and Its Impact on Human Fecal Bacteria

Yong Xie, Ying-jun Fu, Dong-sheng Liu, 2022, Frontiers in Cellular and Infection Microbiology.

Expression of T‐cell Immunoglobulin‐ and Mucin‐domain‐containing Molecules‐1 and ‐3 (Tim‐1 and Tim‐3) in Helicobacter pylori Infection

Wei Liu, Yong Xie, Nan-jin Zhou, 2011, Helicobacter.

Chitosan as an adjuvant for a Helicobacter pylori therapeutic vaccine

Wei Liu, Yong Xie, Nan-jin Zhou, 2015, Molecular medicine reports.

Tim-4 expressing monocytes as a novel indicator to assess disease activity and severity of ulcerative colitis.

Yong Xie, Dong-sheng Liu, Junming Li, 2021, Life sciences.

[Prevalence of Helicobacter pylori cagA, vacA, and iceA genotypes in children with gastroduodenal diseases].

Xuan Zhu, Yong Xie, Dong-sheng Liu, 2016, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics.

Thalidomide is a therapeutic agent that is effective in inducing and maintaining endoscopic remission in adult CD patients.

Zhenhua Zhu, X. Shu, S. Long, 2017, Clinics and research in hepatology and gastroenterology.

Construction and characterization of recombinant attenuated Salmonella typhimurium expressing the babA2/ureI fusion gene of Helicobacter pylori.

Yong Xie, Nan-jin Zhou, Dong-sheng Liu, 2011, Clinics and research in hepatology and gastroenterology.

Ectopic expression of SIGIRR in the colon ameliorates colitis in mice by downregulating TLR4/NF-κB overactivation.

Wei Liu, Yong Xie, Nan-jin Zhou, 2017, Immunology letters.

Furazolidone-based triple and quadruple eradication therapy for Helicobacter pylori infection.

Ji-Rong Wen, X. Shu, N. Lu, 2014, World journal of gastroenterology.

Prevalence of Helicobacter pylori babA, oipA, sabA, and homB genes in isolates from Chinese patients with different gastroduodenal diseases

Qiaoyun Zhao, Yong Xie, Nan-jin Zhou, 2020, Medical Microbiology and Immunology.

Characteristics of Helicobacter pylori antibiotic resistance: data from four different populations

N. Lu, Xuan Zhu, J. Wan, 2019, Antimicrobial Resistance & Infection Control.

New single capsule of bismuth, metronidazole and tetracycline given with omeprazole versus quadruple therapy consisting of bismuth, omeprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a Chinese prospective, randomized, multicentre trial

Jianming Xu, Guoxin Zhang, Z. Zeng, 2018, The Journal of antimicrobial chemotherapy.

Association of TLR4 and Treg in Helicobacter pylori Colonization and Inflammation in Mice

Wei Liu, Yong Xie, Nan-jin Zhou, 2016, PloS one.

The internalization of Helicobacter pylori plays a role in the failure of H. pylori eradication

Yong Xie, Shuping Chen, Y. Zhong, 2017, Helicobacter.

Antibiotic resistance and CYP2C19 polymorphisms affect the efficacy of concomitant therapies for Helicobacter pylori infection: an open-label, randomized, single-centre clinical trial.

X. Shu, N. Lu, Xuan Zhu, 2016, The Journal of antimicrobial chemotherapy.

Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Tria

Z. Zeng, Zhenhua Zhu, Shi-yao Chen, 2018, Antimicrobial Agents and Chemotherapy.

Characteristics of Helicobacter pylori Heteroresistance in Gastric Biopsies and Its Clinical Relevance

Yong Xie, Dong-sheng Liu, R. Zeng, 2022, Frontiers in Cellular and Infection Microbiology.

Genotype profiles of Helicobacter pylori from gastric biopsies and strains with antimicrobial-induced resistance

Qiaoyun Zhao, Linfu Zhou, Yong Xie, 2020, Therapeutic advances in gastroenterology.

Refractory Helicobacter pylori infection and the gastric microbiota

Yong Xie, Dong-sheng Liu, Jinyun Wang, 2022, Frontiers in Cellular and Infection Microbiology.

Overexpression of HMGB1 A-box reduced lipopolysaccharide-induced intestinal inflammation via HMGB1/TLR4 signaling in vitro.

Yong Xie, Nan-jin Zhou, Fucai Wang, 2015, World journal of gastroenterology.

Helicobacter pylori infection reduces the efficacy of cancer immunotherapy: A systematic review and meta‐analysis

Yong Xie, Dong-sheng Liu, Dingwei Liu, 2023, Helicobacter.

Primary antibiotic resistance of Helicobacter pylori in Chinese patients: a multiregion prospective 7-year study.

Y. Li, H. Lu, Z. Zeng, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.